Government News

ICMR Issue latest guidelines for management of type 2 diabetes

  • Posted on: 8 May 2018
  • By: Shalini.Sharma

The International Diabetes Federation (IDF) estimates that there are 72.9 million
people with diabetes in India in 2017, which is projected to rise to 134.3 million by the
year 2045. The prevalence of diabetes in urban India, especially in large metropolitan
cities has increased from 2% in the 1970s to over 20% at present and the rural areas
are also fast catching up.

Central Government strengthens TB cure by making obligatory action from doctors and pharmacists to submit complete info on tuberculosis patients

  • Posted on: 4 May 2018
  • By: PharmaTutor News

Government takes obligatory action for collecting data of all tuberculosis patients to ensure proper tuberculosis diagnosis and its management in patients and their contacts and to reduce tuberculosis transmission and  further to address the problems of emergence and spread of Drug Resistant-Tuberculosis.

Government push pain killer Tramadol under narcotics laws

  • Posted on: 2 May 2018
  • By: PharmaTutor News

Government of India brings Tramadol, a synthetic opioid pain killer, under the control of the Narcotic Drugs and Psychotropic Substances (NDPS) Act 1985. Tramadol is also known as ISIS Drug. ISIS militants are known to abuse tramadol to suppress pain and boost strength during injury. International anti-narcotics authorities also called it as fighter drug.

Indian Patent act need revisions, requests Indian and Foreign pharmaceutical associations

  • Posted on: 11 April 2018
  • By: PharmaTutor News

Indian and foreign pharmaceutical associations need amendment in section 146 of Indian patent act 1970 and form 27 for making Indian patenting system more efficient and it will eliminate vague and unnecessary annual working statement disclosures. Indian patent office has invited responses from stake holders and many pharmaceutical industries and association responded in this regards.

Next stop for Indian pharma companies should be Japan

  • Posted on: 11 April 2018
  • By: PharmaTutor News

Japan continues to be one of the largest pharmaceutical markets in the globe only behind US and China. The country of 12-13 crores population and have greatest potential in pharmaceutical despite difficult demographic landscape. Life expectancy of Japanese population is higher in the world which is almost 80 years for male and 87 years for female. Older people need more medicine and this is the fundamental of pharmaceutical industry in the Japan.

Stem Cells are included as New Drug under D&C rules

  • Posted on: 10 April 2018
  • By: PharmaTutor News

We are living in stem cell era and it is required proper regulation of stem cells in the country. By increasing use of stem cell products, it was required to provide proper guidelines to define new drug under stem cells category. Government have added stem cells as new drugs. They amended rule 122E of the Drugs and Cosmetics (D&C) Rules, 1945 after suggestions from Drug technical advisory board. These rules may be called the Drugs and Cosmetics Amendment Rules, 2018.

Government organized National Conference on Counterfeiting & Role of Enforcement Agencies

  • Posted on: 15 March 2018
  • By: Shalini.Sharma

The Cell for IPR Promotion and Management (CIPAM), a professional body under the aegis of the Department of Industrial Policy & Promotion (DIPP), Ministry of Commerce & Industry, Government of India, is organizing a National Conference on Counterfeiting and Role of Enforcement Agencies on 13th-14th March, 2018 in New Delhi, in collaboration with European Union (EU). Minister of Commerce and Industry, Shri Suresh Prabhu will inaugurate this two-day conference in the presence of DIPP Secretary Shri Ramesh Abhishek.

CCRAS Developed a AYUSH Drug QOL-2C for Cancer Patients

  • Posted on: 14 March 2018
  • By: Shalini.Sharma

The Central Council for Research in Ayurvedic Sciences (CCRAS) is an autonomous body of the Ministry of AYUSH (Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homeopathy), Government of India. It is an apex body in India for the formulation, coordination, development and promotion of research on scientific lines in Ayurveda and Sowa-Rigpa system of medicine.

DBT propose to support research on 'Vitamin D deficiency in India: public health significance and interventions'

  • Posted on: 13 March 2018
  • By: Shalini.Sharma

In view of the recent reports of escalating burden of biochemical VDD and its known skeletal and potential extra-skeletal effects, the Department of Biotechnology proposes to support research on its public health significance and potential interventions to address this malady.